Exchange: OTC·Updated 10:32 AM EDT
EVLO logo

EVLO Evelo Biosciences Inc

$0.0001
$0.00
(0.00%)
Today
Reported EarningsAug 14
Mkt Cap$1,898.00
Vol151.00

About EVLO

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Foxborough, MA.
50

Neutral Sentiment

How do you feel about EVLO?

Advertisement|Remove ads.